PROCEPT BioRobotics® to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference
PROCEPT BioRobotics (Nasdaq: PRCT) said members of management will present at two investor conferences in March 2026: a fireside chat at TD Cowen in Boston on March 2, 2026 at 11:40am ET and a fireside chat at Leerink in Miami on March 10, 2026 at 8:00am ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
PROCEPT BioRobotics (Nasdaq: PRCT) said members of management will present at two investor conferences in March 2026: a fireside chat at TD Cowen in Boston on March 2, 2026 at 11:40am ET and a fireside chat at Leerink in Miami on March 10, 2026 at 8:00am ET.
A live webcast and archived recordings will be available on the company Investors website and retained for at least 90 days after each event.
Details
News Market Reaction – PRCT
On Feb 5, the first trading day after this news, PRCT closed 5.29% below the previous close.
Data tracked by StockTitan Argus for the Feb 5 session.
Key Figures
- TD Cowen fireside chat time
- 11:40 a.m. ET
- TD Cowen 46th Annual Health Care Conference on March 2, 2026
- Leerink fireside chat time
- 8:00 a.m. ET
- 2026 Leerink Global Health Care Conference on March 10, 2026
- Webcast archive period
- 90 days
- Replay availability after each conference event
Historical Context
-
Announced 4Q25 earnings call and Investor Day with webcast access.
-
Planned presentation at Piper Sandler healthcare conference with webcast replay.
-
Reported Q3 2025 growth, margin expansion, and 2026 revenue guidance.
-
Set date and time for Q3 2025 results call and webcast details.
-
Peer Jupiter Endovascular closed oversubscribed Series B and outlined trial plans.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN JOSE, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today that members of management will present at two upcoming investor conferences in March.
TD Cowen 46th Annual Health Care Conference
- Location – Boston, MA
- Fireside Chat – Monday, March 2nd at 11:40am ET
2026 Leerink Global Health Care Conference
- Location – Miami, FL
- Fireside Chat – Tuesday, March 10th at 8am ET
A live webcast of each event, as well as an archived recording, will be available on the “Investors” section of the Company’s website at: https://ir.procept-biorobotics.com. The webcasts will be archived and available for replay for at least 90 days after the event.
About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics’ mission is to revolutionize BPH treatment globally in partnership with urologists by delivering best-in-class robotic solutions that positively impact patients and drive value. PROCEPT BioRobotics manufactures the AQUABEAM® and HYDROS® Robotic Systems. The HYDROS Robotic System is the only AI-Powered, robotic technology that delivers Aquablation therapy. PROCEPT BioRobotics designed Aquablation therapy to deliver effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms or LUTS, due to BPH that are independent of prostate size and shape or surgeon experience. BPH is the most common prostate disease and impacts approximately 40 million men in the United States.
Investor Contact:
Matt Bacso
VP, Investor Relations and Business Operations
m.bacso@procept-biorobotics.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.